Safer Shot Stock Current Asset
| SAFS Stock | USD 0.0001 0.00 0.00% |
Fundamental analysis of Safer Shot allows traders to better anticipate movements in Safer Shot's stock price by examining its financial health and performance throughout various phases of its business cycle.
Safer |
Safer Shot Company Current Asset Analysis
Safer Shot's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, Safer Shot has a Current Asset of 0.0. This is 100.0% lower than that of the Industrials sector and 100.0% lower than that of the Aerospace & Defense industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Safer Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Safer Shot's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Safer Shot could also be used in its relative valuation, which is a method of valuing Safer Shot by comparing valuation metrics of similar companies.Safer Shot is currently under evaluation in current asset category among its peers.
Safer Fundamentals
| Return On Asset | -0.5 | |||
| Current Valuation | 67.25 K | |||
| Shares Outstanding | 1.35 M | |||
| Net Income | (87.23 K) | |||
| Cash And Equivalents | 71 | |||
| Total Debt | 144.93 K | |||
| Book Value Per Share | (0.34) X | |||
| Cash Flow From Operations | (172) | |||
| Earnings Per Share | (0.69) X | |||
| Beta | -104.93 | |||
| Market Capitalization | 3.39 K | |||
| Total Asset | 110.49 K | |||
| Retained Earnings | (3.05 M) | |||
| Working Capital | (506 K) | |||
| Current Liabilities | 506 K | |||
| Z Score | -42.6 | |||
| Net Asset | 110.49 K |
About Safer Shot Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Safer Shot's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Safer Shot using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Safer Shot based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Safer Pink Sheet Analysis
When running Safer Shot's price analysis, check to measure Safer Shot's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Safer Shot is operating at the current time. Most of Safer Shot's value examination focuses on studying past and present price action to predict the probability of Safer Shot's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Safer Shot's price. Additionally, you may evaluate how the addition of Safer Shot to your portfolios can decrease your overall portfolio volatility.